✦ LIBER ✦

Evidence for the continued transmission of parvovirus B19 in patients with bleeding disorders treated with plasma-derived factor concentrates

✍ Scribed by Soucie, J. Michael; Monahan, Paul E.; Kulkarni, Roshni; De Staercke, Christine; Recht, Michael; Chitlur, Meera B.; Gruppo, Ralph; Hooper, W. Craig; Kessler, Craig; Manco-Johnson, Marilyn J.; Powell, Jerry; Pyle, Meredith; Riske, Brenda; Sabio, Hernan; Trimble, Sean

Book ID: 121667994
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 43 KB
Volume: 53
Category: Article
ISSN: 0372-1248
DOI: 10.1111/trf.12153

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Evidence for the transmission of parvovi

Evidence for the transmission of parvovirus B19 in patients with bleeding disorders treated with plasma-derived factor concentrates in the era of nucleic acid test screening

✍ J. Michael Soucie; Christine De Staercke; Paul E. Monahan; Michael Recht; Meera 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 182 KB

Clinical efficacy, safety and pharmacoki

Clinical efficacy, safety and pharmacokinetic properties of the plasma-derived factor IX concentrate Haemonine® in previously treated patients with severe haemophilia B

✍ M. SERBAN; A. B. SKOTNICKI; M. COLOVIC; C. JINCA; A. KLUKOWSKA; P. LAGUNA; D. M. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB

The Evidence for the Use of Recombinant

The Evidence for the Use of Recombinant Human Activated Factor VII in the Treatment of Bleeding Patients With Quantitative and Qualitative Platelet Disorders

✍ Man-Chiu Poon 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 345 KB